**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 1314-91-6 |Lead telluride | 99.99 | 215-247-1 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 20/22 33 61 62
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed. Danger of cumulative
effects. May cause harm to the unborn child. Possible risk of
impaired fertility.The toxicological properties of this material have
not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. The toxicological properties of this substance have not
been fully investigated. Ingestion of lead compounds can cause toxic
effects in the blood-forming organs, kidneys and central nervous
system. May cause systemic effects. Symptoms of lead poisoning
include; weakness, weight loss, lassitude, insomnia, and hypotension.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated. Overexposure may
lead to headache, dizziness, abdominal pain, diarrhea, constipation,
nausea, vomiting, 'blue line' on the gums, insomnia, and a metallic
taste in the mouth.
Chronic:
May cause liver and kidney damage. Chronic exposure may lead to
encephalopathy.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid immediately. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or
alcohol-resistant foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Sweep up, then place into a suitable container for disposal. Avoid
generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Avoid ingestion and inhalation.
Storage:
Keep containers tightly closed. Store in a cool, dry area away from
incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 1314-91-6:
United Kingdom, WEL - TWA: (listed as lead compounds): 0.15 mg/m3
(as Pb)
United Kingdom, WEL - STEL: (listed as lead compounds): 0.45 mg/m
TWA (as Pb)
United States OSHA: 0.1 mg/m3 TWA (listed under Tellurium).50 ??g
TWA (as Pb); 30 ??g/m3 Action Level (as Pb. Poison - see 29 CFR
1910.10 25) (listed under Lead, inorganic compounds).
Belgium - TWA: (listed as lead, inorganic compounds): 0.15 mg/m3
(dust and fume)
France - VME: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Germany: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Japan: (listed as lead compounds): 0.1 mg/m3 OEL (except alkyl le
compounds, as Pb)
Malaysia: (listed as lead, inorganic compounds): 0.05 mg/m3 TWA (
Pb)
Netherlands: (listed as lead, inorganic compounds): 0.15 mg/m3 MA
(dust and smoke, as Pb)
Russia: (listed as lead, inorganic compounds): 0.5 mg/m3 TWA (as
Spain: (listed as lead, inorganic compounds): 0.15 mg/m3 VLA-ED (
Pb)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals
Color: not available - white
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 905 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: insoluble
Specific Gravity/Density: 8.164 g/L
Molecular Formula: PbTe
Molecular Weight: 334.79
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids, metal oxides.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, tellurium fumes, lead fumes.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 1314-91-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Lead telluride -
California: carcinogen, initial date 10/1/92 (listed as Lead compounds
NTP: Suspect carcinogen (listed as Lead compounds).
IARC: Group 2A carcinogen (listed as Lead, inorganic compounds).
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3288
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 3288
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, INORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 3288
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 61 May cause harm to the unborn child.
R 20/22 Harmful by inhalation and if swallowed.
R 33 Danger of cumulative effects.
R 62 Possible risk of impaired fertility.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 1314-91-6: No information available.
Canada
CAS# 1314-91-6 is listed on Canada's DSL List.
CAS# 1314-91-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1314-91-6 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #3 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
8-Anilino-1-naphthalenesulfonic acid magnesium salt, 95% (uv-vis)
| 18108-68-4 |
|
Nonadecanoic acid, 99%
| 646-30-0 |
|
Hydrocinnamic Acid, 99+% (GC)
| 501-52-0 |
|
N-Methyldioctylamine, 98%
| 4455-26-9 |
|
n-Pentadecanoic acid, 99%
| 1002-84-2 |
|
Cesium hydroxide
| 21351-79-1 |
|
Triphenylmethyl mercaptan
| 3695-77-0 |
|
2,3,3',4'-Tetramethoxybenzophenone, 98%
| 50625-53-1 |
|
2,3,4-Trimethoxybenzaldehyde, 99%
| 2103-57-3 |
|
Dichloromalononitrile, 97%
| 13063-43-9 |
|
n-(5-Anilino-2,4-pentadienylidene)aniline hydrochloride, 98% (hplc)
| 1497-49-0 |
|
2,6-Dichlorobenzoic Acid, 98+%
| 50-30-6 |
|
3-Benzyloxy-4-Methoxybenzaldehyde, 98%
| 6346-05-0 |
|
2-Chloro-6-Fluorophenylacetonitrile, 98%
| 75279-55-9 |
|
3-Pyridinealdoxime, 98%
| 1193-92-6 |
|
Dibenzoylmethane, 98%
| 120-46-7 |
|
Lead telluride, 99.99%
| 1314-91-6 |
|
Benzoxazole, 99+%
| 273-53-0 |
|
DL-Asparagine Monohydrate, 98%
| 3130-87-8 |
|
2-Aminoresorcinol Hydrochloride, 97% (Titr.)
| 634-60-6 |
|
Sesame Oil
| 8008-74-0 |
|
N-1-(6-Indazolyl)-Sulfanilamide
| 13734-41-3 |
|
3-(4-Methoxyphenyl)-propionic acid, 98%
| 1929-29-9 |
|
1-Phenylnonane, 97%
| 1081-77-2 |
|
3,5-Dichloroanthranilic Acid, 97%
| 2789-92-6 |
|
N-(Tert-Butyl)Benzylamine, 99%
| 3378-72-1 |
|
2'-Bromoacetophenone, 98+%
| 2142-69-0 |
|
Chlorotrimethylsilane, 98%
| 75-77-4 |
|
Linalyl acetate,synthetic, 95-97%(gc)
| 115-95-7 |
|
5,7-Dibromo-8-hydroxyquinoline, 96%
| 521-74-4 |
|
Molecular Sieves, 5A, 4 to 8 Mesh
| 0-00-1 |
|
4-Chloro-3-Nitrobenzaldehyde, 97%
| 16588-34-4 |
|
2-Amino-5-Chlorobenzotrifluoride, 97%
| 445-03-4 |
|
Phosphorus Trichloride, 99% (Titr.)
| 7719-12-2 |
|
2-Methyl-1,3-pentadiene (cis/trans mixture 30/70),99%
| 1118-58-7 |
|
4-Bromo-3-Methylaniline, 99%
| 6933-10-4 |
|
Adipic Acid Monoethyl Ester, 98%
| 626-86-8 |
|
2-Guanidinobenzimidazole, 95%
| 5418-95-1 |
|
Diisobutyl phthalate, 99+% (GC)
| 84-69-5 |
|
Vinylacetic Acid, Tech., 90% Unstabilized
| 625-38-7 |
|
4-Propylbenzoyl Chloride, 99+% (Titr.)
| 52710-27-7 |
|
Hexanoic anhydride, 99%
| 2051-49-2 |
|
2-Hydroxy-6-methylpyridine-3-carboxylic acid, 98%
| 38116-61-9 |
|
5-Benzyloxygramine 99+%
| 1453-97-0 |
|
Ethyl 2-Methylacetoacetate, 98%
| 609-14-3 |
|
2-Fluoro-4-iodotoluene, 99+%
| 39998-81-7 |
|
Tris-(2-Methylallyl)-Amine, 99%
| 6321-40-0 |
|
Hydroxypivalyl hydroxypivalate
| 1115-20-4 |
|
DL-alpha-pinene, 97%
| 2437-95-8 |
|
FMOC-Glycine, 98%
| 29022-11-5 |
|
|